RN7SL2

Across TCGA pan-cancer cohorts, RN7SL2 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RN7SL2 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher RN7SL2 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RN7SL2 expression acts as an unfavorable survival marker, although some lineages such as CHOL and UCS show a favorable association.

CHOL, UCS, and CESC are the cancer types where RN7SL2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	DFS	Tertile	All	0.669	0.162	<.001	52	view →
UCS	OS	Tertile	All	0.545	0.176	.003	42	view →
CESC	OS	Median	All	0.920	0.818	.002	24	view →
UCEC	OS	Tertile	IV	0.752	0.272	.004	22	view →
ACC	DFS	Median	All	0.276	0.615	.003	21	view →
COAD	OS	Median	IV	0.621	0.290	.003	20	view →
KICH	OS	Quartile	II,III,IV	0.451	1.000	.001	17	view →
SKCM	OS	Quartile	IV	0.849	0.259	.004	17	view →
THCA	OS	Median	All	1.000	0.985	.016	13	view →
LUAD	DFS	Median	II,III,IV	0.737	0.623	.017	11	view →
UVM	OS	Quartile	III,IV	0.294	0.848	.031	7	view →
STAD	DFS	Tertile	III,IV	0.674	0.466	.024	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

RN7SL2–CHOL (DFS)

Open the CHOL breakdown →